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The aim of this study was development of biocompatible topical microemulsions (MEs) for 
incorporation and improved dermal delivery of sertaconazole nitrate (SN). For this purpose, 
phase behavior and microstructure of pseudo-ternary surfactant glycereth-7-caprylate/caprate 
(Emanon EV-E, EV)/cosurfactant/ Capryol
TM
 90/ water systems were investigated. Furhermore,  
the influence of these properties on the drug skin delivery was also assessed. Glycereth-7-
caprylate/caprate (Emanon EV-E, EV) was used as surfactant, whereas Transcutol
®
 P, ethanol, 
isopropyl alcohol, glycerol and propylene glycol were evaluated as cosurfactants. Expansion of 
microemulsion ME single-phase regions with the use of short chain alcohols was a consequence 
of the more fluid interface when compared to other investigated systems, which was confirmed 
by electron paramagnetic resonance spectroscopy – EPR (obtained rotational correlation time 
values ranged from 1.55 ns to 3.83 ns). Bicontinuous to inverted bicontinuous inner 
microstructure of the selected vehicles with different qualitative (and quantitative) composition 
was suggested by comprehensive physicochemical characterization. The chosen bicontinuous to 
inverted bicontinuous formulations were assessed against the microemulsion ME based on 
polysorbate 80 as referent sample. Despite incorporation of SN within the selected formulations 
induced similar alternations in electrical conductivity, viscosity and pH values. Depending on 
formulation composition, obtained EPR spectra suggested different SN localization: within the 
oil phase (for most of the EV based formulations), or interacting with the interface (polysorbate 
80 based formulation). Due to higher in vitro drug release (12.24% - 18.53%), ex vivo SN 
penetration into porcine ear skin (dermal retention Enhancement Ratio (ERD) ranged from 2.66 
to 4.25) and pronounced antifungal activity, the chosen MEs represent promising vehicles for 















released from MEs was in range of 12.24% - 18.53%, which was significantly higher in 4 out of 
5 investigated MEs in comparison with the commercial product (10.33%). Similar findings were 
revealed in ex vivo SN penetration experiment into the porcine ear skin - Dermal Retention 
Enhancement Ratio (ERD) ranged from 2.66 to 4.25. The biopharmaceutical and skin 
performance differences obtained with different formulations were possible to be explained on 
the basis of their physicochemical characteristics. Due to the higher SN penetration into the skin 
and pronounced antifungal activity, the chosen MEs represent promising vehicles for dermal 
delivery of SN in treatment of cutaneous fungal infections. 
Keywords: glycereth-7-caprylate/caprate, sertaconazole nitrate, microemulsion, electron 
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The major obstacle in the conventional topical treatment of deep fungal skin infections, where 
therapeutic effects should be restricted to the affected area and systemic incrimination reduced, is 
the uppermost layer of the skin, the stratum corneum. Namely, the effectiveness of a topically 
applied antifungal agent is directly related to its ability to reach  at least the viable epidermis [1]. 
But, the latter one is mostly dependent on the drug physicochemical properties and the vehicle 
used for its administration [2]. Considering that many antifungals are poorly soluble and have 
low skin permeability [1], development of a suitable formulation, capable of drug delivering  to 
the target skin layer, is highly challenging. As an imidazole derivative which inhibits the 
synthesis of ergosterol, sertaconazole nitrate (SN) is indicated for the treatment of dermatophyte 
infections (tinea corporis, tinea cruris, tinea manus, tinea barbae and tinea pedis), cutaneous 
candidiasis, vaginal candidiasis, pityriasis versicolor and seborroeic dermatitis of the scalp [3]. 
However, SN has unfavorable physicochemical properties regarding topical administration, i.e. 
poor aqueous solubility with high partition coefficient (logP = 6.2) [1], hindering its practical use 
and leading to low  dermal bioavailability. In order to deliver SN into deeper skin layers, 
different strategies and modern drug carriers have been recently proposed [4-10]. Among them, 
microemulsions (MEs) seem to be particularly appealing due to their numerous advantages. As 
spontaneously and easily prepared, optically isotropic, transparent, low viscous dispersions of 
oil, water, surfactant and often cosurfactant, MEs are thermodynamically stable and offer well 















for enhanced drug permeation has not been completely elucidated, several possibilities are 
suggested: higher solubilization capacity coupled with high concentration gradient, increased 
drug thermodynamic activity, relatively high surfactant/cosurfactant content, as well as some 
specific properties related to the inner structure of this nanocarrier [11-14]. However, there is a 
constraint on topical MEs formation arising from excipients acceptability and high amounts of 
surfactants associated with potential skin irritating effect. Therefore, a large number of studies 
involved nonionic, biodegradable, nontoxic surfactants, which are either synthetic or of natural 
origin. Among synthetic tensides used to stabilize MEs, polyethoxylated surfactants, such as 
polysorbates, seem to be most frequently used due to their minimal toxicity reported [15]. 
Although a great number of investigations have dealt with the use of polyoxyethylene (glycerol) 
fatty acid esters as stabilizers in ME systems [2], to the best of our knowledge, none of these 
formulations have been based on glycereth-7-caprylate/caprate (Emanon EV-E, EV). Hence, in 
order to investigate deeper the EV's ability to form stable MEs, we extended our previous study 
[16] and tested the emulsification power and phase behavior of the aforementioned surfactant in 
the presence of several usually employed cosurfactants/cosolvents (Transcutol
®
 P, ethanol, 
isopropyl alcohol, propylene glycol, glycerol). Based on the hypothesis that structural differences 
in the used cosurfactants may result in distinct nanostructures with different physicochemical 
properties, skin tolerability, as well as the capability for dermal drug delivery [12, 13, 17], we 
investigated physicochemical and biopharmaceutical characteristics of several placebo and SN-
loaded MEs obtained with EV in combination with different cosurfactants, comparing them 
mutually. A comparison was also made related to the ME stabilized with polysorbate 80 (P80), 
which served as the referent ME carrier, as well as to the commercially available drug product 















with enhanced skin retention without compromising antifungal activity of the drug. However, 
despite the extensive studies, a real therapeutic efficacy of ME formulation can hardly be 
predicted. Therefore, an attempt to correlate physicochemical characteristics of the investigated 
vehicles to their biopharmaceutical performances was also made. In this course, samples were 
subjected to the conductivity studies, differential scanning calorimetry (DSC), atomic force 
microscopy (AFM) and electron paramagnetic resonance (EPR) analysis coupled with the one 
year storage-stability study and in vitro SN release and porcine ear skin permeation/penetration 
assessment followed finally by in vitro antifungal activity evaluation.  
2. Materials and methods 
2.1. Materials 
SN and SN reference standard were purchased from Shanghai Pengteng Fine Chemical 
(Shanghai, China) and Sigma Aldrich (Steinheim, Germany), respectively. EV was kind 
donation from Kao Chemicals (Barbera del Valles, Spain), whereas propylene glycol 
monocaprylate (Capryol
TM
 90, C90) and highly purified diethylene glycol monoethyl ether 
(Transcutol
®
 P) were kindly gifted from Gattefosse (Lyon, France). Propylene glycol was 
supplied by Kemig (Zagreb, Croatia), P80 by Sigma–Aldrich Laborchemikalien GmbH (Seelze, 
Germany), ethanol by ZorkaPharm (Sabac, Serbia), isopropyl alcohol and glycerol by Lach-Ner 
(Neratovice, Czech Republic). 5-doxyl stearic acid (5-DSA) was the product of Sigma-Aldrich, 
(Steinheim, Germany). HPLC grade water was obtained with a GenPure apparatus (TKA water 
purification system, Niederelbert, Germany). Mycosert
®
 cream was provided by pharmacy store. 
















2.2. Construction of pseudo-ternary phase diagrams and preparation of MEs 
Phase behavior of systems comprising of oil (C90), surfactant-cosurfactant mixture (S-CoS) and 
water was explored by construction of pseudo-ternary phase diagrams, using water titration 
method. Different weight ratios of C90 and S-CoS mixture ranging from 1:9 to 9:1 (w/w) were 
prepared and water was gradually added in a drop wise manner (Vortex Mixer, Velp Scientifica, 
Italy). The S-CoS mass ratio (Km) was kept at 1. Boundaries of ME area were determined 
according to the largest amount of water incorporated in homogenous, single-phase, low viscous 
and transparent ME samples. The appearance of opalescence or turbidity was considered as an 
indicator of phase separation. Further, selected MEs were prepared by mixing the oil with S-CoS 
for 15 min at magnetic stirrer (Falc, Italy). Then the proper amount of water was added with 
gently magnetic stirring for another 30 min. SN was dissolved in the pre-weighted ME vehicles 
under continuous mixing at magnetic stirrer for 2h followed by ultrasonication for 15 min to give 
a final concentration of 2% (w/w). 
2.3. Microemulsion characterization 
2.3.1. Polarized light microscopy 
Transparent placebo and drug loaded ME samples were submitted to polarization microscopy 
(Olympus BX51-P, Olympus Corporation, Tokyo, Japan) in order to confirm their isotropy and 
complete solubilization of SN in final vehicles.   
2.3.2. Electrical conductivity 
Electrical conductivity measurements were carried out at room temperature using SensION 

















evaluate the MEs’ inner structure water was added gradually into the initial mixture of S-CoS 
and oil, and conductivity of obtained samples was checked after the equilibrium was attained. 
Bearing in mind that phase behavior of nonionic tensides and thus ME nanostructure can be 
altered in the presence of electrolytes due to the modification of ionic strength of water phase 
and its chemical potential [18, 19], this study was performed without electrolyte addition. 
Measurements were made in triplicate for each sample. 
2.3.3. Rheological measurements 
The rheological properties of the prepared ME formulations was assessed on DV-III ULTRA 
Programmable Rheometer & Rheocalc software v.4.3 (Brookfield Engineering Laboratories, 
Middlesboro USA), coupled with cone and plate measuring device at 20 ± 1°C. Measurements 
were performed in triplicate at shear rates in range of 75-750 s
-1
, for both, up and down curves. 
2.3.4. pH analysis  
The pH values of MEs were measured using pH meter (HI9321, Hanna Instruments, Portugal). 
Experiments were performed in triplicate for each sample. 
2.3.5. Differential scanning calorimetry (DSC) measurements 
In order to obtain further insight into the microstructure and type of prepared MEs, the physical 
state of water in nonionic MEs was investigated by using low-temperature DSC (Mettler Toledo 
DSC 1, STAR
e
 System (Mettler Toledo AG, Analytical, Switzerland)). DSC cooling curves were 
conducted with approximately 10 mg of ME samples weighted into aluminum pans and quickly 















hermetically sealed pan. Placebo ME formulations were cooled from 25°C to –60°C (cooling 
rate: 5°C/min) under constant nitrogen flow (50 ml/min).  
2.3.6. Atomic force microscopy (AFM) 
Surface morphology of the chosen placebo ME was observed using atomic force microscopy 
(NTEGRA prima AFM, NT-MDT, Moscow, Russia) operating in intermittent-contact AFM 
mode in air and NT-MDT NSGO1 silicon cantilevers (N-type, Antimony doped, Au reflective 
coating). For more details, please consult the supplementary material section. For this purpose, a 
drop (10 µL) of the sample was directly deposited onto a small, circular mica substrate (Highest 
Grade V1 AFM Mica Discs; Ted Pella Inc., Redding, California) and dried in desiccator for 48 h 
to remove excess water. During the measurements, experimental conditions were set as follows: 
nominal force constant 5.1 N/m, resonance frequency 87–230 kHz, driving frequency 148 kHz, 
and line scanning frequency 1 Hz. For the investigated samples, two types of images, topography 
and “error signal” AFM images, were taken and later analyzed using the software Image 
Analysis 2.2.0 (NT-MDT, Moscow, Russia). 
2.3.7. Electron paramagnetic resonance spectroscopy (EPR) 
EPR using the spin-probing technique was employed in order to study microenvironment 
properties of the interface comprising of S-CoS monolayer and to investigate drug interactions 
with the interface of selected MEs on molecular level [20, 21]. The spin probe having capability 
to reflect ordering and dynamics of the interfacial film at different depths was used: the doxyl 
free radical, 5-doxyl stearic acid [5-(1-oxyl-2,2-dimethyl-oxazolidin) stearic acid, 5-DSA). As a 
fatty acid, 5-DSA has an amphiphilic nature deriving from the presence of a polar head group (-















of the nitroxide paramagnetic ring (doxyl group) at the 5
th
 carbon atom of the hydrocarbon chain, 
the unpaired electron is located closer to the polar head of the fatty acid and consequently closer 
to the S-CoS polar head group area [22, 23]. 5-DSA was added in the systems as described 
previously [20]. For detailed description of the experimental procedure and analysis of the 
experimental results, please consult the supplementary material section. Briefly, to obtain the 
desired concentration of the spin probe in the MEs, 1 ml of each ME was added to a tube into 
which the appropriate amount of the spin probe had been deposited previously. More 
specifically, 15 μl of an ethanolic stock solution of 5-DSA (        M) were transferred in the 
tube and the solvent was allowed to evaporate at room temperature. The samples remained 
overnight in a water bath (25°C). Final concentration of 5-DSA in the MEs was 0.117 mM. 
EPR spectra were recorded at constant room temperature (25°C), using a Bruker EMX EPR 
spectrometer operating at the X-Ban, USA. Experiments were conducted with the use of a WG-
813-Q Wilmad (Buena, NJ) Suprasil flat cell. Typical instrument settings were: Center field: 
0.349 T, scan range: 0.01T, gain:         , time constant: 5.12 ms, modulation amplitude: 0.4 
mT and frequency: 9.78 GHz. Data collection and analysis were performed using the 
BrukerWinEPR acquisition and processing program.  
Experimental results were analyzed in terms of rotational correlation time (  ), order parameter 
(S) and isotropic hyperfine splitting constant (α
'
ο). The rotational correlation time,   , of the spin 
probes was calculated from the EPR spectra according to the following equation [24]:  
        
             
            
          (s)                                                      (1) 
where    ,   , and     represent the amplitudes of the three hyperfine lines respectively and 















motion region, i.e. for     in the range   
           
   s, where spin probes are sensitive 
to small changes in their microenvironment. Therefore, the variation of the    values reflects the 
restrictions imposed on its motion from the specific microenvironment. For the slow motion 
region (       
  s) the rotational correlation time,   , is calculated with the use of 
computer simulations assuming average rotational correlation times. 
From the spectral characteristics, two more parameters were calculated: the order parameter, S, 
and the isotropic hyperfine splitting constant, α΄o. The order parameter ( ) describes the 
orientational order of spin probe depending on its arrangement in a supramolecular assembly. S 
varies from       for perfectly ordered membranes to     for the completely random state. 
From EPR spectra,   is calculated using the following relationship [21, 22]:  
                                  
                                                                             (2) 
where    ,    , and     are the single-crystal values of the spin probe indicative for doxyl 
derivatives and are equal to 0.63, 0.58 and 3.36 mT, respectively. The ratio   
     is the polarity 
correction factor (hyperfine splitting constants), where    is                     and   
  
is the isotropic hyperfine splitting constant for the spin probe in the membrane and is defined as  
  
            .    corresponds to the half distance of the outer maximum hyperfine splitting 
(    ), while    is defined as: 
               
                                                                                                             (3) 
and 
                                                                                                        (4) 















The hyperfine splitting constant, reflecting the polarity in the environment of the doxyl 
paramagnetic ring, can be also calculated directly from the EPR spectrum.   
  value is taken as 
the distance between the first and the second line (peak) of the first derivate of the EPR 
spectrum. The   
  value is sensitive to the polarity of the environment of the spin probe and is 
increased when the polarity of the medium is increased. 
2.3.9. Saturation solubility of SN in MEs 
The saturation solubility of the drug in chosen ME formulations was determined by shake flask 
method. An excess drug amount was added in the selected formulation (5 mL) and stirred 
continuously (IKA
®
 KS 260 basic shaker, IKA
®
 Werke GmbH & Company KG Staufen, 
Germany) for 72 h at mixing rate of 300 rpm at room temperature to reach equilibrium. After 
removal of undissolved drug by centrifugation (3000 rpm for 30 minutes (Centrifuge Rotofix 32 
A, Hettich, Tuttlingen, Germany)), the supernatant was filtered through 0.22 µm membrane filter 
(Chromafil
®
 Xtra PTFE-20/25, Macherey-Nagel, Düren, Germany) and concentration of the drug 
was determined by using high performance liquid chromatography methodology (HPLC). 
2.4. Stability study 
Physical and chemical stability of SN loaded MEs and of their blank counterparts stored at the 
room temperature (20 ± 3 °C) was assessed at different time points during a year of storage. 
2.5. In vitro release of sertaconazole nitrate 
In vitro drug release profiles of The selected SN loaded ME formulations (Table 1) and referent 
cream were assessed utilizing vertical diffusion (Franz) cells (Gauer Glas, D-Püttlingen, 















chamber (effective diffusion area: 2.01 cm
2
) was filled with precise volume (12 mL) of degassed 
preheated (32 °C) mixture of ethanol and water (50:50 v/v) and continuously stirred with a 
magnetic stirrer at 500 rpm. Previously activated dialysis membranes (with a pore size of 2.4 nm 
and molecular weight cut-off 12000) were carefully mounted between donor and receptor 
compartments. The investigated MEs (1 g) were placed on the membranes, spread to cover entire 
membrane, and then covered with occlusive Parafilm
TM
 to prevent any evaporation. The 
temperature of diffusion cells was maintained at 32 °C throughout the experiment using 
circulating water bath. Aliquots (600 µL) were withdrawn and replaced with an equal volume of 
fresh pre-warmed medium after 30 min, 1 h, 2 h, 3 h, 4 h, 6 h and 8 h of samples application. The 
withdrawn samples were analyzed for SN concentration using HPLC method. The results are 
expressed as the cumulative amount of drug released per unit area (µg/cm
2
) plotted versus time 
(t), allowing the determination of in vitro transmembrane flux for each investigated ME sample. 
In order to compare the obtained drug release profiles, statistical and model-dependent 
approaches were proposed. 
2.6. Ex vivo penetration and permeation assessment 
Ex vivo penetration and permeation test was conducted using porcine ears obtained from the 
local abattoir,. Immediately after slaughter, the porcine ears were washed under cold running 
water, blotted dry with a soft tissue and stored at  20 °C. Briefly, on the day of the experiment, 
they porcine ears were thawed at room temperature. In order to remove visible hairs from the 
skin, a hair clipper was used. Afterwards, subcutaneous fat was removed from the skin with a 
surgical blade and the skin pieces, having a diameter of 25 mm and suitable for permeation 
studies, were punched. The obtained skin sections were checked for any physical damage and 















porcine ear skin pieces were clamped between the donor and receptor compartments of modified 
Franz diffusion cells (Gauer Glas, D-Püttlingen, Germany) with 2.01 cm
2
 permeation area and 12 
mL receptor cell volume. The stratum corneum layer was positioned on the assembly facing the 
donor compartment. The investigated formulations (1 g) were carefully applied to the skin 
surface. Experiments were carried out in triplicate, at 32 °C, using ethanolic water (50:50 v/v) as 
receptor medium, stirred constantly at 500 rpm. Samples (600 µL) were withdrawn at 
appropriate intervals (2 h, 4 h ,6 h, 8 h and 24 h) over 24 h and immediately replaced with the 
same volume of freshly prepared medium kept at the same temperature. In order to determine the 
drug permeated, the aliquots were submitted to HPLC analysis. Finally, at the end of the 
permeation test, the skin samples were removed, wiped clean three times with PBS (pH = 7.4) to 
remove excess formulations and cut into small pieces. Then, the skin pieces were transferred to 
capped volumetric flasks filled with 5 ml of methanol and subjected to SN extraction by mixing 
on  a laboratory shaker for 24 h (IKA
®
 Werke GmbH & Company KG Staufen, Germany). 
Afterwards the content of flasks was sonicated (Sonorex RK 120H, Bandelin, Berlin, Germany) 
for 30 min in order to ensure maximum extraction of the drug and then centrifuged at 4000 rpm 
for 20 min (Centrifuge MPW-56; MPW Med. Instruments, Warszawa, Poland). The obtained 
supernatants were filtered (membrane filter 0.45 µm) and HPLC analysis was conducted in order 
to determine SN concentration. 
2.7. In vitro antifungal activity 
The selected ME formulations along with Mycosert
®
 cream were assayed for their antifungal 
activity against the fungal strain Candida albicans. In order to evaluate antifungal efficacy of the 
tested samples the cup plate diffusion method was employed. Candida albicans was grown on 















The cups were cut using sterilized cork borer, while MEs and cream were accurately filled into 
different cups with the aid of sterilized syringes. The Petri dishes were then covered with lids 
and incubated at 37±0.1 
°
C for 24 h to allow fungal growth. The antifungal activity was 
expressed as zone of inhibition (mm) of fungal growth surrounding the formulations. All 
determinations were made in triplicate for each sample. 
2.8. Drug analysis 
The drug quantification was carried out with the use of the established HPLC method [25]. For 
more detail on the method, please consult the supplementary material section. The HPLC 
analysis was performed on Dionex Ultimate 3000 system (Thermo Fisher Scientific, Dreieich, 
Germany) equipped with Dionex Ultimate 3000 quaternary pump, autosampler and DAD 
detector. The column chosen was Zorbax Eclipse XDB-C18 (150 mm × 4.6 mm, 5 µm particle 
size). The mobile phase consisted of methanol and 0.2% formic acid (70:30, v/v). The column 
temperature was adjusted to 30ºC and the flow rate was 1 ml/min. The detection was performed 
at 260 nm.  
2.9. Data analysis 
All the tests were performed in 3-6 replicates and data were expressed as the average value ± SD. 
The data were statistically analyzed by one-way analysis of variance (ANOVA), with statistical 
significance set at p < 0.05, which was considered as significant with 95% confidence intervals. 
Statistical analysis was performed using Microsoft Excel software package. 
3. Results and discussion 















According to the manufacturer’s specification, EV is a vegetable-based, eco-friendly nonionic 
surfactant, being both biodegradable and with low toxicity. It is generally used for hair and skin 
care applications and characterized with high content of monoester and a very high value of HLB 
(HLB ~ 17) as well. However, in order to develop pharmaceutically applicable ME systems 
based on novel, scarcely characterized surfactants such as EV, phase behavior studies are 
prerequisite. Indeed, the recognition of the phase behavior and water solubilization capacity of 
nonionic surfactants in the system are considered as key factors for formation of MEs as 
potential drug delivery systems [26]. As the mutual miscibility of the oil and surfactant and the 
consequent oil emulsification are greater if the oil and surfactant chain length are similar [27], 
propylene glycol monocaprylate (C90) was selected as the oil phase. Moreover, C90 and EV as 
well showed a high potential to dissolve the drug [16]. However, taking into account that a single 
surfactant is usually not sufficient to form a stable ME, five distinct cosurfactants were varied 
(Transcutol
®
 P, ethanol, isopropyl alcohol, propylene glycol and glycerol) in order to assess their 
influence on the rigidity/flexibility of the interfacial film, and hence, on the single-phase area. 
Figure 1a shows different pseudo-ternary phase diagrams obtained with EV as surfactant, 
Transcutol
®
 P, ethanol, isopropyl alcohol or propylene glycol as a cosurfactant, C90 as the oil 
and double distilled water. It should be pointed out that EV is able to produce MEs in the 
absence of cosurfactants only with oil:S-CoS ratios 9:1 and 8:2 (data not shown). Under these 
conditions, maximum water incorporation along the dilution line 8:2 was 16.67% (w/w), while 
the initial mixture oil:S-CoS equals 9:1 was fully dilutable. However, the usage of 
aforementioned cosurfactants resulted in widening of the single phase area obtained with the 
surfactant alone. As expected, the maximum water incorporation was reached at very low oil 















coarse emulsions were formed. Comparing the effects of the tested cosurfactants, it could be 
noticed that the smallest ME area was obtained when propylene glycol was used as cosurfactant. 
Interestingly, EV in a combination with glycerol had no efficacy in formation of ME systems. 
The largest area of MEs’ existence was obtained with isopropyl alcohol because it was probably 
the best distributed between the hydrocarbon chains of oil and surfactant increasing the 
interfacial flexibility and making the interface less sensitive to water dilution. Hence, ME area 
increased as the chain length of alcohol increased from ethanol to isopropyl alcohol, while the 
increase of hydroxyl groups number from isopropyl alcohol to propylene glycol reduced the size 
of ME zone such as glycerol completely abolished the single phase area that was in line with 
previously reported findings obtained with polysorbate 80 and lecithin [20, 28, 29]. Introduction 
of cosurfactants into oil/water/surfactant system leads to further reduction of interfacial tension 
and affects surfactant packing, allowing the interfacial film to be sufficiently flexible to take up 
adequate curvatures necessary for ME formation over a wide range of composition [28-31]. 
Depending on their polarity/amphiphilicity, the low molecular weight cosurfactants are 
distributed between the oil and water, affecting the hydrophilicity/lipophilicity balance [30]. In 
fact, the size of ME areas obtained with cosurfactants used in this study can be correlated with 
their partition coefficients as a measure of their polarities, which in turn determine the 
solubilization locus of cosurfactants in ME systems. Analyzing the obtained results, it seems that 
a cosurfactant’s ability to penetrate into the amphiphilic film decreases with increasing polarity. 
Indeed, the most polar cosurfactant (glycerol, logP = -1.76) produced no MEs, whereas the 
widest ME area was obtained with the least polar one (isopropyl alcohol, logP = 0.05). 
Accordingly, less polar cosurfactant, such as isopropyl alcohol, inserts itself among the 















to water dilution and increased the mutual miscibility of oil and water. On the other hand, 
propylene glycol and glycerol having two and three free hydroxyl groups, respectively, probably 
migrated from the interface and were mostly located in water phase. As a result, the amphiphiles 
concentration at the interface was reduced by water addition, destabilizing the ME system. 
Further, despite both used monohydric alcohols have one hydroxyl group, ethanol produced 
narrower single phase area than isopropyl alcohol, which can be also attributed to higher polarity 
of ethanol (logP = -0.31).  Finally, the decrease of the total ME area in the case of Transcutol
®
 P 
(logP = -0.54) when compared to short chain alcohols may be also attributed to its higher 
polarity. On the other hand, Transcutol
®
 P produced wider ME area than propylene glycol 
because propylene glycol (logP = -0.92) is too soluble in the aqueous phase and thus less 
effective as cosurfactant.  
These results undoubtedly demonstrate that EV, as nonionic surfactant with high HLB value 
(~17), can be included to the list of polyethoxylated surfactants capable of forming ME systems 
over wide range of costituents. Qualitative and quantitative compositions of MEs determine their 
inner structure, physicochemical characteristics, droplet shape and size and affect the placement 
and the fate of a particular solute such as drug molecule [11, 12, 32]. When it comes to dermal 
drug delivery, the drug has to liberate from the vehicle in order to penetrate into the skin. The 
liberation process is dependent on the hosting environment properties, such as physicochemical 
characteristics and dynamics. Cohen-Avrahami and coworkers [33] have recently demonstrated 
that the release of sodium diclofenac was significantly greater from the cubic mesophase than 
from the lamellar system due to the different drug interactions with the respective interfaces. 
Also, it has been already reported that dermal delivery of the hydrophobic antifungal drug is 















inner structures cannot be completely anticipated from the obtained phase diagrams. Therefore, 
structural characterization was further conducted.   
3.2. Structural characterization and selection of samples 
In order to assess microstructural changes upon dilution with water, electrical conductivity (κ) 
was measured and plotted as a function of water content (Φw). Despite slightly lower water 
solubilization along the dilution line S-CoS:oil=8:2 than along the line 9:1, we selected the 
dilution line 8:2 for further structural characterization with the intention to reduce surfactant 
content in final formulations, increasing their biocompatibility [19]. In addition, the maximum 
drug penetration enhancement is usually not obtained if the amount of surfactant in formulation 
was the highest [2, 13, 32].  
Figure 1b shows changes of electrical conductivity (κ) of the investigated systems with gradual 
increase of water, until maximum water was added within the single-phase ME areas. As can be 
noticed, the investigated systems containing less than 10% of water had low electrical 
conductivity values. With further addition of water up to maximal water solubilization, 
conductivity increased to the maximal values. This can be explained with the progressive 
increase in hydration of ethylene oxide moieties of EV, rendering a better conducting entity. 
Namely, below a critical value of Φw water molecules are isolated from each other because being 
embedded in the non-conducting continuous oil phase, contributing very little to the electrical 
conductivity [14, 34]. As water if further added, the number of non-interacting droplets is 
greater, reaching its critical value and leading to interlinking and clustering of the droplets, 
which reflects as a pronounced rise of conductivity. However, the analysis of the obtained 















isopropyl alcohol and propylene glycol. Therefore, the exact points of microstructure transition 
from water-in-oil (w/o)) to oil-in-water (o/w) MEs through emergence of bicontinuous systems 
were not observable. In order to assess the validity of percolation theory and elucidate the 
percolation threshold, the first derivative of κ (dlog(κ)/dΦw) was plotted as a function of Φw. The 
first derivative approach allows the determination of a percolation threshold from a maximum in 
the curve [35]. Hence, quantity of dlog(κ)/dΦw was evaluated for each system and presented in 
Figure 1b. In accordance with our previous assumptions, phase transitions occurred at very low 
water contents in each of the studied systems. Actually, considering ethanol based system, it is 
possible that percolation was achieved even in sample with no water added. This can be 
explained on the basis of certain residual amount of water present in ethanol (96% v/v), used in 
this study. Therefore, the sample without externally added water may contain per se enough 
water to produce bicontinuous structure instantly. Since the maximum of the curve can be 
noticed when fraction of water added equals zero, it seems that phase transition from w/o to 
bicontinuous microstructure had been already occurred or it was ending in this point. Similar 
lack of percolation threshold point was noticed in lecithin based MEs costabilized with ethanol 
[20].  
However, in other investigated ME systems, the presence of percolative behavior was confirmed 
with observable sharply peaked maximum values of the plots showing dlog(κ)/dΦw versus Φw  
(Figure 1b). The obtained maximal values were at 2, 2.5 and 3%, for systems containing 
propylene glycol, Transcutol
®
 P and isopropyl alcohol, respectively. As revealed by phase 
behavior studies, more polar cosurfactants are less solubilized in the surfactant interfacial film. 















interface and enhanced interdroplet interactions. As a result, percolation threshold was more 
easily achieved.  
Taking into account the results obtained by using electrical conductivity measurements, EV was 
capable to produce w/o and/or bicontinuous MEs along the selected dilution line (8:2). Because 
the second slope on the respective curves implying inversion from bicontinuous to o/w MEs is 
not visible, fully developed water continuous systems were not anticipated. Bearing in mind that 
bicontinuous MEs have several benefits over globular type of MEs, i.e. higher amphiphilic 
character, greater fluctuating interface, a lower interfacial tension and improved solubilizing 
properties [36], we selected vehicles with presumed (inverted) bicontinuous microstructure as 
carriers for SN. In addition, o/w and bicontinuous MEs are generally considered as carriers 
which enhance penetration/permeation of hydrophobic drugs much more than oil continuous 
microemulsions [2, 12, 32]. Hence, the selection was done based on the ability of the sample 
with minimum surfactant and maximum water content of solubilizing the drug therapeutic 
concentration (2% w/w) and satisfying preliminary stability. The composition of the selected 
formulations and SN solubility within these samples are given in Table 1. With the exception of 
ME with propylene glycol, such a selection allowed us to elaborate the influence of cosurfactant 
type on MEs properties. However, the formulation with propylene glycol contained less water 
than other samples. Although SN could be solubilized within this sample, the ME with 30% of 
water phase was near the border of the respective single phase area and it was excluded due to 
potential stability issues. In addition, quantitatively the same ME based on P80 as commonly 
employed surfactant in ME formulation was used. Transcutol
®
 P was chosen as cosurfactant in 















In order to further check the results obtained with electrical conductivity measurements and 
confirm the internal microstructure of the selected vehicles, DSC in cooling mode was carried 
out. Namely, by analyzing samples with DSC, a differentiation between different physical states 
of water within dispersed systems can be accomplished. This is based on the fact that bound 
(immobilized internal or interfacial) water has freezing point at subzero temperatures, while free 
bulk water molecules, located far from the interfacial layer and thus having high mobility, freeze 
in the vicinity of zero degrees [14, 37]. Cooling curves of the selected vehicles (Table 1), in spite 
of having 25-30% of water, resulted in no freezing peaks (Figure 2), suggesting their oil-
continuous inner structure characterized with non-freezable aqueous phase [27, 38]. However, 
according to Podlogar et al [38] and Goebel et al [37], the absence of an exothermic water peak 
could be explained with the strong interactions between S-CoS molecules with water, which 
shifted freezing of water towards lower temperatures. Taking into account that the chosen 
samples contain at least 28% (w/w) of surfactant and 28% (w/w) of cosurfactant, the hydration of 
the hydroxyl groups of surfactant and cosurfactants cannot be neglected. Moreover, having in 
mind C90’s surface active properties and one free hydroxyl group, the interactions between 
water and oil can be also suggested. Consequently, water freezing point moved towards lower 
temperatures, which were probably out of the detected range. Therefore, strong interactions in 
the investigated systems were proposed as the main reasons for the disagreement between the 
results obtained with electrical conductivity and DSC.  
On the other hand, AFM as a rarely used direct technique for ME characterization supported the 
assumptions revealed by using indirect methods. The AFM images – error signal and 3D 
topography of the chosen ME-EVI are illustrated in Figure 3. As can be seen from the 















lack of long-range order and fluctuating interface separating mutually intertwined oil and water 
domains. However, non-uniform rare oil droplets can be also observed, implying the onset of 
system inversion from bicontinuous to water-continuous MEs. High electrical conductivity value 
of ME-EVI argues in favor of this claim.  Additionally, it is important to note that MEs, as 
highly dynamic systems, spontaneously and continuously undergo fluctuations including phase 
transitions and changes in droplet size [13].  Furthermore, it should be also underlined that the 
difficulty was found in obtaining high quality images due to problems with sample preparation 
resulted in incomplete removal of excess liquid. Briefly, the tested samples must be attached to a 
surface in order to prevent movement, sample’s damage and modifications, which could 
potentially induce the microstructure and surface phenomena changes. Nevertheless, the obtained 
AFM results enabled the differentiation of the MEs from the geometrically ordered lamellar 
liquid crystals structures with higher viscosity and pseudo-plastic flow behavior [27, 34]. 
3.3. Physicochemical characterization of the selected MEs  
Considering that even slight changes in composition of MEs reflect on their physicochemical 
characteristics and consequently on drug biopharmaceutical properties, comprehensive 
physicochemical characterization was carried out in order to gain insight into drug-vehicle 
interactions and factors involved in drug release and penetration. Physicochemical properties of 
the selected MEs are presented in Table 2 and Figure 4.  
Polarization microscopy results were in high agreement with AFM microscopy, suggesting the 
lack of liquid crystalline structures for placebo samples as well as SN-loaded MEs. pH values of 
the tested placebo samples were in range of 4.13-7.47. Solubilization of SN within the MEs 















application. The dramatic decrement of pH values was attributed to the presence of strongly 
acidic nitrate anions in aqueous phase. EV-based samples characterized with slightly distinct pH 
values, whereas the reference sample stabilized with P80 had significantly lower pH.  
Electrical conductivity is considered to be a structure-sensitive property of a ME system. The 
rank order of conductivity values of EV based MEs (ethanol > isopropyl alcohol > Transcutol
®
 P 
> propylene glycol) may be also related to the polarity and the location of each cosurfactant in 
the respective systems. For example, propylene glycol has the highest hydrophilicity and most 
likely it migrated out of the interface into the water phase to a greater extent than the other 
cosurfactants. Consequently, hydration of its hydroxyl groups took place, restricting the mobility 
of water molecules and hence the electrical conductivity values decreased. Due to the presence 
of one hydroxyl group in their structures, ethanol and isopropyl alcohol were less hydrated than 
1,2-propanediol. In addition, short chain alcohols were probably mostly located within the 
interfacial film interacting with surfactant more strongly than the other two cosurfactants. This 
made them less available for hydrogen bonding with water molecules. Hence, mobility of water 
phase was higher, resulting in higher conductance as well.  
Similar to the drug influence on pH, electrical conductivity values were also strongly affected by 
SN incorporation, which was also explained with the fact that nitrate anions increased the 
conductance by passing through water channels.  
All selected MEs had low viscosity values (8.96-48.79 mPas) and characterized with Newton 
flow behavior (Figure 4a), which is the most common flow type for ME systems. According to 
the obtained low viscosity values together with polarization microscopy and AFM results, the 















based ME had the highest value of apparent viscosity (48.79 ± 1.17). Having in mind that this 
sample had the same concentration of all ingredients as the ME-EVT formulation, one can 
conclude that the surfactant type and its structure affected rheology of the investigated ME 
systems. Namely, the surfactant having lower molecular weight (i.e. EV with Mr of 301.34) 
produced lower viscosity than P80 characterized with Mr 524.6. In addition, due to the larger 
number of the very hydrophilic polyoxyethylene head groups in its structure, P80 probably 
interacted via hydrogen bonds with water molecules more strongly, which reflected on the 
sample’s viscosity. This observation coincides well with the lower conductivity values obtained 
for C90/P80/Transcutol
®
 P/water system due to the more pronounced restriction of water 
mobility. In parallel with this trend, viscosity of quantitatively the same EV based formulations 
increased with increasing molecular weight of cosurfactants (ethanol < isopropyl alcohol < 
Transcutol
®
 P) and was was in a range of 8.96 to 18.84 mPas. Apparently the propylene glycol 
based sample did not obey this relation. However, it should be noticed that ME-EVPG sample 
had less water and larger amount of other components (i.e. S-CoS and oil) than the other samples 
based on the same surfactant, which was determinant factor influencing its viscosity (32.63 ± 
0.94 mPas). Also, 1,2-propanediol has an additional hydroxyl group in contrast to ethanol and 
isopropyl alcohol, thus an increase in the degree of hydration and higher viscosity may be 
expected. 
Although the addition of SN did not alter MEs’ flow behavior, the viscosity of drug-loaded 
samples was higher than of placebo MEs (11.90-51.01 mPas), suggesting that the drug 
influenced the microstructure of the investigated samples in a way that the droplet size increased 
or higher degree of S-CoS hydration was achieved. However, the change of viscosity was not of 















as well as the composition of selected samples (Table 2), solubility of SN in ME constituents 
[16] and logP value of the drug (6.2), the major fraction of the drug was probably partitioned 
between the oil phase and the less polar part of the interface. 
Finally, with the intention to shed light on the interfacial properties of the S-CoS monolayer of 
MEs in the absence and the presence of the drug and thus to confirm our assumptions about the 
locus for drug solubilization, we further employed EPR spectroscopy. The spin-labeled 
amphiphilic fatty acid-5-DSA was used as a spin probe. This interface-located fatty acid spin 
probe gives EPR spectra reflecting the rigidity/flexibility of its environment from the depth of 
the membrane where the doxyl-ring of the 5-DSA is located. As a result, (i) alterations caused in 
the membrane in the presence of different types of surfactants/co-surfactants and (ii) the 
localization of the drug in the ME systems, were evaluated. In the case of 5- DSA the doxyl 
group is located closer to the polar head of the amphiphilic fatty acid and consequently closer to 
the S-CoS polar heads. However, it should be highlighted that EPR spectra of 5-DSA (pKa = 
7.45) is pH dependent and the knowledge of sample’s pH is strongly required for spectra’s 
analysis [21].   
The obtained results are presented in Figure 4b and Table 3. The investigated systems composed 
of C90/EV/cosurfactant/water showed distinct interfacial properties as expected. In the case of 
ME-EVPG system, the remarkable increase in the    value could be due to the nature of 1,2-
propanediol which restricts the rotational movement of the spin probe [39]. The observed 
decrease of the spin probe’s mobility could be also explained by the reduction of the water 
content of the system, drastically affecting the microenvironment. In addition, ME-EVPG system 
contains higher quantity of oil and S-CoS mixture (Table 1) and has higher viscosity as well 















decrease of water content also affected the order parameter values indicating the passing from a 
rather flexible packing of membrane to a more ordered state. The 5% w/w decrement of the 
water content also reflects on the value of the   
  which was also reduced and indicates a less 
polar environment.  
On the contrary, very low    values were recorded for the MEs which are composed of C90, EV, 
cosurfactant and 30% of water. In this case not only    values were decreased but also the order 
parameters were decreased from 0.17±0.02 to 0.11±0.01. When short chain alcohols were used 
as cosurfactants, the mobility of the spin probe was clearly affected with a characteristic 
alteration in the experimental spectrum where the peaks were narrower than those on ME-EVPG 
and ME-EVT systems (Figure 4b). This was a consequence of a more “free” movement of the 
spin probe when alcohols are present in the MEs creating a more polar and less strict 
environment for the mobility of the spin probe. Furthermore, the S parameter is also affected 
with a less rigid surfactant monolayer as observed in ME-EVI and ME-EVE systems. Therefore, 
the EPR studies were in consistence with phase behavior studies demonstrating a more flexible 
interfacial film for systems based on alcohols, which allowed the incorporation of larger amount 
of water. 
Analyzing the influence of different surfactants on interfacial film properties, the higher    value 
obtained for ME-P80T (Table 3) was probably due to the higher viscosity of P80 as compared to 
EV and the consequent difficulty of the paramagnetic nitroxide ring to rotate in the membrane.  
Therefore, the replacement of EV with another ethoxylated surfactant clearly shows that the 
rigidity of the membrane (parameter S), in the depth where the paramagnetic ring of the spin 
probe is located, was also affected since an increase from 0.15±0.01 to 0.16±0.03 was observed. 















neglected as it could cause changes of the experimental EPR spectra. Namely, at higher pH 
(7.47) some of 5-DSA molecules (pKa = 7.45) might be ionized and thus located closer to the 
hydrophilic head groups of the surfactants. Contrary, in ME-P80T sample (pH = 4.42) only the 
unionized form of 5-DSA is expected. In this case the position of the doxyl group is among the 
hydrophobic tails of the surfactants, providing information only of this specific 
microenvironment.  
EPR measurements of the five systems in the presence of SN were undertaken in order to obtain 
information about the possible drug effect on the interface of the formulations (Table 3). As 
shown in Table 3, for the 3 out of 5 systems (i.e. ME-EVT, ME-EVI and ME-EVE) the order 
parameter S and the rotational correlation time    were not affected in the presence of SN, within 
the experimental error, meaning that the membrane rigidity remains unaltered after the 
incorporation of the drug. This is also corroborated with the fact that SN solubilization did not 
decrease formulations’ micropolarity, which was anticipated from highly lipophilic character of 
SN. It has to be underlined that the part of the membrane that is examined with the use of 5-DSA 
is the part closer to the polar head of the spin probe’s paramagnetic ring. Hence, it can be 
concluded from the above findings that SN is embedded within the oil. However, it cannot be 
excluded that the drug was also distributed among hydrophobic tails of the S-CoS, at least 
partially. In contrast to this, in the systems ME-P80T and ME-EVPG the incorporation of the 
drug seems to impose important restrictions on the mobility of the spin probe. In both cases,    
and S values appeared to be remarkably increased indicating drug’s participation in the less polar 
membrane of the formulations. In the ME-EVPG system the increase in the S-CoS and oil 
content made the solubilization of the SN easier (Table 1). It seems that SN modified the 















5-DSA probe to insert deeply among the hydrophobic surfactant tails, where the movement is 
less restricted. On the other hand, isotropic hyperfine splitting constants (  
 ) did not change 
meaning that the recognizable environmental polarity of the paramagnetic moiety of 5-DSA is 
the same in the absence and in the presence of SN in all systems.  
To summarize, the EPR did not detect any significant change at the polar part of the interface of 
the tested MEs caused by SN solubilization. According to this, the lipophilic drug is mainly 
distributed in the oil phase. Also, it cannot be excluded that some SN molecules are embedded 
between hydrophobic tails of the interfacial film in the vicinity of the oil phase. Although 
without statistical importance, the solubilization of SN in ME-EVPG and ME-P80T samples 
affected the polar part of the respective S-CoS monolayers in a different manner than of other 
investigated MEs implying the drug presence at the membrane. Different hosting microstructure 
in the latter samples could affect biopharmaceutical properties of the drug carriers [33].  
However, significantly distinct pH of placebo and drug loaded samples (Table 2) should be taken 
into consideration, as at the acid environment (SN-loaded MEs) the paramagnetic ring senses the 
hydrophobic surfactant tails. Under these conditions 5-DSA dominantly exists in the unionized 
form and might be shifted in the nonpolar part of the interface affecting the EPR spectra. 
Therefore, the conclusions about SN effects on the interfacial film are difficult to make and 
should be taken cautiously, especially for ME systems based on EV, since their pH values are 
remarkably altered after drug incorporation. 















During a year of storage there had no signs of any physical change of placebo and SN loaded 
formulations, i.e. opalescence, turbidity, phase separation, SN precipitation. This was somehow 
anticipated, bearing in mind that ME systems are characterized with thermodynamic stability.  
However, other investigated properties were altered, i.e. pH values as well as electrical 
conductivity (Table 2). The slight pH decrement observed for all samples can be attributed to the 
presence of free fatty acids as products of gradual hydrolytic degradation of C90. Due to the 
greater number of hydrogen ions, the increase in electrical conductivity was intuitively expected 
and it occurred in placebo samples and drug loaded MEs as well.  
During the storage of a year at the room temperature, the drug content in MEs did not 
significantly change (Figure 5), suggesting acceptable preliminary stability of samples. This 
result also confirms that the conductivity and pH changes were derived from C90’s degradation. 
3.5. In vitro release of sertaconazole nitrate 
Given that in vitro release study can provide useful information on the influence of various 
factors involved in delivery of a drug into the skin, its therapeutic efficacy and indirectly its 
bioavailability [40], we investigated whether or not the differences in composition and overall 
microstructure of selected MEs reflected on their in vitro liberation properties. The assessment of 
potential of novel colloidal drug carriers (MEs) to improve SN delivery into the skin departments 
was carried out in vitro using vertical diffusion cells (i.e. Franz cells) equipped with synthetic 
membranes.  
 As presented in Figure 6 and Table 4, greater cumulative amount (µg/cm
2
) of SN was released 
from all MEs in comparison to the referent commercial product. The corresponding 















only in the case of ME-EVT sample (p = 0.07). The drug release profiles observed for the 
investigated MEs were similar to each other. SN release occurred according to the zero order 
kinetic described with a linear relationship between the cumulative amount of SN released per 
unit area and time. This kinetic model indicates constant, concentration-independent drug 
release. Hence, it may be considered as an advantage as the drug retention within the skin for 
prolonged period could be expected. Contrary, drug release from the reference cream, somehow 
expected, differed from MEs and fitted best to the Higuchi model, suggesting that the drug 
released by diffusion controlled by the vehicle, and also reflected that SN is, at least partly, 
suspended within the vehicle.   
The released amounts of the drug from ME vehicles were generally low and after 8h of the 
experiment reached values of 12.24-18.53% of the applied drug amount (Table 4). Nevertheless, 
a concentration of the drug released at the end of the experiment was less than 30% of the total 
amount of the drug applied in the donor compartment. Hence, the drug diffusion back into donor 
compartment was avoided and a “30% rule” was fulfilled [41].  
As can be seen from Table 4, the amount and rate of drug release highly depended on the 
formulation composition with ME-EVT sample producing lower release rates when comparing 
with other formulations. Further, when analyzing quantitatively same EV based systems with 
distinct cosurfactants, a release-enhancing effect of short chain alcohols was evident. However, 
the difference between the influence of ethanol and isopropyl alcohol was not statistically 
important. Correlating the drug release with physicochemical characteristics of the formulations, 
it appears that the differences in rheological behavior influenced SN liberation from the 
investigated formulations. Cumulative amount of drug released was remarkably higher from the 















(Figure 4b, Table 3), the microenvironment of the interface of ME-EVE and ME-EVI was more 
polar and less ordered than of ME-EVT vehicle. As a result of such an environment, the 
migration of SN through the interface with looser packing occurred in an enhanced manner [33]. 
Also, the S-CoS monolayer of these MEs, especially its polar part, had lower solubilization 
capacity for highly lipophilic drug, resulting in higher thermodynamic activity of SN and thus 
higher drug release. This is in agreement with the capacity of formulations for drug 
solubilization (Table 1). Accordingly, as the solubility of the drug in EV based systems was 
higher, the release of SN was lower most likely due to higher thermodynamic activity of the 
drug. Similar behavior was noticed by Zvonar and coworkers [42]. Indeed, the drug release 
followed the rank order ME-EVE > ME-EVI > ME-EVPG > ME-EVT, while the saturation 
solubility for SN was totally opposite. Therefore, it can be deduced that in EV containing 
formulations SN release was inversely dependent on the solubilization capacity of the carriers. 
On the other hand, the results produced with ME-EVPG formulation can be explained neither 
with rheological properties nor on the basis of the micropolarity and interface mobility of the 
samples. According to the lower water content, lower values of   
 , more ordered microstructure 
and higher viscosity of the propylene glycol based sample than of ME-EVT, lower drug release 
was expected. Surprisingly, the release of SN was slightly higher from ME-EVPG formulation. 
The explanation for this can be different locus for SN solubilization revealed by EPR, lower 
solubilization capacity for the drug and higher thermodynamic activity.  
Finally, the type of surfactant also seemed to play an important role, since SN release from ME-
P80T, differing from ME-EVT only in surfactant type, was significantly higher (Figure 6, Table 
4) in comparison with not only with ME-EVT but also with all other MEs. Unexpectedly, ME-















implying that rheological properties had no decisive role on drug liberation. However, the 
explanation for this phenomenon might also be the lower solubility of the drug in P80 based ME 
system (Table 1) as well as in its constituents [16]. Furthermore, SN increased the microviscosity 
and the order degree of the interfacial film of ME-P80T, hinting that the drug interacted to the 
certain extent with the polar part of S-CoS monolayer and increased the interactions between its 
constituents toward denser packing. This process could maybe induce the occurrence of droplet 
water-continuous structure which reflected positively on drug liberation. Namely, drug mobility 
is higher if the drug is located at the interface of o/w microemulsions [12]. 
Taking overall release results in parallel with the solubility results (Table 1), the characteristics 
of the formulations (Table 2) and EPR study results (Figure 4b, Table 3), it can be deduced that 
SN release was predominantly dependent on the solubility of the drug within the studied 
formulations and the localization of the drug within the MEs. Viscosity of the drug loaded 
samples and the amount of water in MEs also might contribute in the process of drug liberation. 
Due to considerably higher release of SN, for further ex vivo penetration and permeation 
investigations we chose ME-EVE, ME-EVI and ME-P80T samples. 
In addition, the obtained in vitro drug release findings suggested that the choice of ME 
constituents should be made carefully. Namely, a usual way to select ME ingredients is primary 
based on drug solubility study in various oils and amphiphiles. Excipients with highest potential 
to solubilize the investigated drug are considered to be most appropriate. Interestingly, according 
to our study, not only broader single phase areas can be produced, but also higher drug release 
















3.6. Ex vivo penetration and permeation assessment 
Considering that porcine skin is commonly regarded as suitable model to predict in vivo situation 
on human skin, penetration/permeation test was carried out on porcine ear skin and results for the 
investigated ME formulations are presented in Figure 7 and Table 5. Delivery of SN was 
assessed according to the SN content penetrated into the skin per surface area (µg/cm
2
) after the 
experiment had finished. This parameter was also used as a measure of formulation dermal 
delivery efficacy. As can be noticed, incorporation of SN in MEs increased the drug skin 
delivery significantly, compared with the referent cream formulation, with dermal delivery 
enhancement ratios (ERD) in a range of 2.66-4.25 (Table 5). The high drug loading capacity of 
MEs, skin hydration by MEs and formulation components acting as skin penetration enhancers 
can be the reasons for better skin delivery performances of MEs over Mycosert
®
 [12, 14, 28].  
Among the MEs tested, ME-EVE sample provided the highest amount of the drug retained in the 
skin, which made it superior over other two MEs (ERD = 4.65). Unexpectedly, P80 based sample 
emerged as at least efficient regarding targeting the drug into the skin despite the liberation of 
SN from this ME was the highest. Since SN concentration was the same in all three MEs, 
concentration gradient of the drug could not be regarded as decisive factor for differences in drug 
penetration. Our former in vivo study [16] showed that ME-P80T and ME-EVT samples had 
satisfying preliminary safety profiles and did not induce skin barrier impairment. However, 
although without statistical importance, a slightly higher increase of eritema index values was 
observed for the sample based on EV as the main surfactant. Therefore, stronger EV’s interaction 
with skin lipids might be suggested, reducing the stratum corneum barrier function and 















short chain alcohols most likely contribute significantly to this effect, due to their well 
established penetration enhancing properties [43, 44].  
In agreement with the amounts of SN released from the MEs stabilized with ethanol and 
isopropyl alcohol, which were slightly different, the efficacy of ME-EVE for drug retention 
within the skin turned out to be insignificantly higher due to the high standard deviation of the 
results. Similar results suggesting more pronounced effect of MEs containing ethanol have been 
also reported by other authors [20, 28, 45] . However, due to the residual amount of water in 
ethanol (96% v/v), ME-EVE formulation probably contained more water than the other samples. 
Hence, the increased dermal hydration by ethanol based formulation and hence more pronounced 
opening of channels for drug transport may be expected [12, 20]. Anyway, the proposed 
mechanism should be confirmed with appropriate in vivo skin performances study of ME 
formulations. 
Comparing the obtained skin penetration results with the release results (Table 4), interestingly 
the formulations were not ranked in the same manner. Indeed, in terms of skin penetration the 
rank was ME-EVE > ME-EVI > ME-P80T > Mycosert
®
, while the drug release was ranked as 
ME-P80T > ME-EVE > ME-EVI > Mycosert
®
. Accordingly, we can conclude that the dermal 
delivery of the drug was not dependent on drug release and was in contrast to the SN liberation 
from the MEs. In fact, as the release from ME systems was slower, the drug retention in the skin 
was higher, confirming the proposed prolonged action of SN after loading in MEs. Moreover, the 
rank of skin penetration was opposite to the rank of drug loading, which was ME-EVE < ME-
EVI < ME-P80T. Therefore, the decreased SN skin retention of P80 based sample may be 
attributed to the different SN distribution, higher drug solubility and thus higher affinity for the 















penetration enhancers contributed to SN skin penetration. It seems that short chain alcohols in 
combination with EV had more pronounced influence when compared with Transcutol
®
 P and 
P80. Although Transcutol
®
 P is considered to have an intrinsic enhancing effect per se [47], it 
has already shown that its power was lower than the efficacy of aforementioned alcohols [43]. 
Namely, short chain alcohols are known to improve the flux of MEs by altering the system’s 
hydro/lipophilicity. Furthermore, due to penetration of cosurfactant in surfactant monolayer the 
interfacial film is getting more fluid. Similarly, the presence of alcohol affects the rotational 
freedom of skin lipid acyl chains leading to the fluidization of the intercellular lipid matrix [44]. 
Thus, beside from the influence on drug solubility in the vehicle, ethanol also alters the structure 
of the biomembrane by lipid extraction and its fluidization resulting in an increased permeability 
of the drug increases [29]. Indeed, EPR study revealed that the interface consisting of EV and 
short chain alcohols was more fluid and thus more fluctuating. This could enhance the 
interactions of ME-EVE and ME-EVI formulations with the skin. In addition, a possible 
explanation for the observed findings may be the supersaturation process and the increase of SN 
thermodynamic activity as a consequence. This occurs if a formulation contains any volatile 
constituents, which is the case with ME-EVE and ME-EVI samples. However, since occlusive 
conditions were set up during the entire permeation experiment, the evaporation was prevented 
and its impact was hence negligible. 
Considering the permeation of SN through the skin, it should be emphasized that no SN was 
detected in receptor fluid under the experimental settings used. Accordingly, the entrance of the 
drug to systemic circulation is prevented, providing the avoidance of the systemic adverse 















Taking together the overall results of this study, in spite of containing different cosurfactants, a 
superiority of EV based formulations for SN dermal delivery over the sample containing P80 as 
the main surfactant could be suggested. Regarding the influence of different cosurfactants, a 
higher penetration efficacy could be ascribed to the sample costabilized with ethanol, 
reproducing findings already reported [20, 28, 45]. When it comes to prediction of formulations’ 
ability to deliver a drug in/across the skin, our results showed that physicochemical and 
biopharmaceutical characteristics can sometimes be misleading. The conducted 
permeation/penetration study underlined the necessity of comprehensive characterization of 
novel vehicles (such as MEs) for dermal drug delivery, which should include an adequate skin 
penetration/permeation test.  
3.7. In vitro antifungal activity 
The antifungal efficacy of the developed ME formulations, i.e. ME-EVE, ME-EVI and ME-
P80T, was assessed and compared with commercially available drug product (Mycosert
®
 cream) 
as a positive control and physiological saline buffer as a negative control. Figure 8 clearly 
illustrates the fungal growth and ability of each tested formulation to inhibit it. The study 
revealed that all of the tested samples were significantly more effective in inhibiting the fungus 
growth than the commercial cream (Figure 8, Table 5). The average zones of inhibition, 
indicating the antifungal efficacy of drug encapsulated in the MEs, were presented in Table 5. 
The microbiological studies were observed not to be synchronous with the ex vivo permeation 
studies. To be more precise, the most effective formulation turned to be the ME-P80T, having 
the mean zone of inhibition against Candida albicans 48.0 ± 2.65 mm, followed by ME-EVI and 















skin penetration ability. Therefore, besides from ME-EVE and ME-EVI formulations, ME-P80T 
could be also further developed as a promising carrier for targeted dermal delivery of SN. 
4. Conclusion 
The present study demonstrated that Emanon EV-E as a poorly explored surfactant for 
pharmaceutical preparations can be successfully employed for formulation of prospective 
colloidal drug carries for dermal drug delivery such as MEs. Stable systems are producible in 
combination with different cosurfactants (i.e. Transcutol
®
 P, ethanol, isopropyl alcohol, 
propylene glycol) and over wide range of components’ content. omprehensive physicochemical 
characterization using electrical conductivity measurements, DSC, AFM and EPR studies was 
carried out in order to investigate the possibility of formation systems with different inner 
microstructures. MEs having (inverted) bicontinuous structure had shown to be appropriate for 
solubilization of the antifungal drug SN. Despite the incorporation of SN in the selected ME 
vehicles induced pH decrease accompanied by the increase of electrical conductivity and 
apparent viscosity. However, in spite of these alternations, the MEs’ properties remained 
acceptable for skin application. Also, EPR study proved that introduction of the drug in ME 
systems did not significantly influenced the polar part of the water-oil interface, suggested the oil 
phase and the part of the interface closer to oil phase as the most important locus for SN 
solubilization. However, the interface of ME-P80T and ME-EVPG formulations was less polar 
and thus more capable to accommodate lipophilic SN. The stability study revealed certain 
changes of pH and conductivity, whereas the drug content was found to be insignificantly 
altered. Beside from having adequate physicochemical characteristics and preliminary stability, 
the developed MEs had superior drug release properties over commercial drug product. The drug 















penetration/permeation study results highlighted the favorable performances of  the samples 
based on short chain alcohols as compared with the formulation obtained with commonly used 
surfactant polysorbate 80, which produced the fastest SN liberation. Finally, ME-EVE, ME-EVI 
and ME-P80T proved to be more effective in inhibition of fungal growth than the tested 
commercial formulation. Therefore, due to the high SN penetration into the skin and pronounced 
antifungal activity, the chosen MEs represent promising vehicles for dermal delivery of SN in 
treatment of cutaneous fungal infections. However, in order to confirm the potential of MEs to 
deliver the drug into the infectious skin, further in vivo study of their effectiveness in animal 
or/and human models are strongly required. 
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Figure 1. a) Pseudo-ternary phase diagrams of systems C90/EV/cosurfactant/water, using as 
cosurfactants: Transcutol P, ethanol, isopropyl alcohol and propylene glycol, from the top to the 
bottom (marked regions represent ME systems, lines represent investigated dilution lines 8:2 
with marked position of selected formulations) and b) electrical conductivity (mean ± SD, n = 3) 
of S-CoS/oil systems upon dilution with water (top) and the first derivative dlog(Κ)/dΦw as a 
function of the water volume fraction (Φw) (bottom) 
Figure 2. DSC thermograms of investigated MEs in cooling mode 
















Figure 4. a) The flow curves of selected placebo and drug loaded MEs and b) the EPR spectra of 
5-DSA for placebo ME samples 
Figure 5. Content of SN in selected MEs during one year of storage at room temperature  
Figure 6. In vitro release of SN from investigated MEs determined across the synthetic dialysis 
membrane (mean ± SD, n = 6) 
Figure 7. The total amount of SN penetrated from investigated MEs and the reference into the 
porcine ear skin ex vivo 
Figure 8. In vitro antifungal activity of ME-EVE, ME-EVI and ME-P80T samples compared 





Table 1. Composition of selected formulations and SN saturation solubility within the samples 
Formulation ME-EVT ME-EVE ME-EVI ME-EVPG ME-P80T 
Capryol
TM
 90 14.0 14.0 14.0 15.0 14.0 
Emanon EV-E 28.0 28.0 28.0 30.0 - 
Polysorbate 80 - - - - 28.0 
Transcutol
®
 P 28.0 - - - 28.0 
Ethanol - 28.0  - - 
Isopropyl alcohol - - 28.0 28.0 - 
Propylene glycol - - - 30.0 - 
Water 30.0 30.0 30.0 25.0 30.0 
Solubility of SN 
(mg/mL ± SD) 
















Table 2. Physicochemical characteristics of investigated MEs 48 h after preparation and after a 
year of storage at room temperature 
Formulation 










placebo 7.47 ± 0.12 62.50 ± 1.01 6.70 ± 0.01 76.63 ± 0.49 
SN loaded 4.39 ± 0.04 268.00 ± 2.00 4.27 ± 0.03 292.33 ± 0.58 
ME-EVE 
placebo 7.37 ± 0.09 94.63 ± 1.15 6.87 ± 0.02 116.47 ± 0.30 
SN loaded 4.65 ± 0.10 445.67 ± 4.04 4.52 ± 0.02 471.00 ± 1.73 
ME-EVI 
placebo 7.44 ± 0.03 71.50 ± 0.62 6.67 ± 0.06 81.047 ± 0.26 
SN loaded 4.62 ± 0.06 319.67 ± 2.31 4.38 ± 0.03 338.00± 1.00 
ME-EVPG 
placebo 7.38 ± 0.06 41.10 ± 0.62 6.88 ± 0.04 50.77 ± 0.06 
SN loaded 4.60 ± 0.08 182.00 ± 2.46 4.42 ± 0.03 204.33 ± 0.58 
ME-P80T 
placebo 4.42 ± 0.03 21.50 ± 1.10 4.28 ± 0.01 22.40 ± 0.10 




Table 3. Rotational correlation time (  ), order parameter (S) and isotropic hyperfine splitting 
constant (  
 ) of 5-DSA in placebo and drug-loaded MEs 
Formulation 
 5-DSA 
    (ns) S   
  
ME-EVT 
unloaded 2.99±0.06 0.15±0.01 14.06±0.03 
SN-loaded 2.81±0.05 0.15±<0.01 14.24±0.12 
ME-EVE 
unloaded 1.55±0.04 0.11±0.01 14.75±0.01 
SN-loaded 1.55±0.03 0.11±0.01 14.77±0.01 
ME-EVI 
unloaded 1.60±0.01 0.11±0.01 14.69±0.04 
SN-loaded 1.56±0.06 0.11±0.01 14.70±0.16 
ME-EVPG 
unloaded 3.83±0.08 0.17±0.02 13.64±0.13 
SN-loaded 4.26±0.19 0.21±0.03 13.65±0.17 
ME-P80T 
unloaded 3.14±0.01 0.16±0.03 13.85 
















Table 4. Release parameters of MEs and control formulation containing 2.0 % (w/w) of SN 















ME-EVT 163.97 ± 3.90 1218.39 ± 41.41 12.24 ± 0.42 zero (0.9927) 
ME-EVE 217.87 ± 21.70 1562.44 ± 178.45 15.70 ± 1.79 zero (0.9937) 
ME-EVI 206.64 ± 6.94 1524.44 ± 46.84 15.32 ± 0.47 zero (0.9967) 
ME-EVPG 167.88 ± 2.28 1278.05 ± 38.21 12.84 ± 0.38 zero (0.9925) 





127.58 ± 4.75 1027.95 ± 10.42 10.33 ± 0.10 Higuchi (0.9942) 
 
 
Table 5. Skin penetration study results and antimicrobial activity of MEs and control 














ME-EVE 61.14 ± 15.17 4.25 40.0 ± 3.6 
ME-EVI 43.22 ± 11.53 3.00 44.0 ± 0.87 
ME-P80T 38.28 ± 7.01 2.66 48.0 ± 2.65 
Mycosert
®

















 Emanon EV-E was capable to produce microemulsion system over wide range of 
components 
 SN affected physicochemical characteristics of systems 
 Microemulsions enhanced in vitro drug release and dermal retention when compared with 
the control formulation 
 Antifungal activity was greater in microemulsions 
 Microemulsion formulations represent promising vehicles for topical application of SN 
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